PL1708753T3 - The use of goat serum for veterinary treatment - Google Patents

The use of goat serum for veterinary treatment

Info

Publication number
PL1708753T3
PL1708753T3 PL04820092T PL04820092T PL1708753T3 PL 1708753 T3 PL1708753 T3 PL 1708753T3 PL 04820092 T PL04820092 T PL 04820092T PL 04820092 T PL04820092 T PL 04820092T PL 1708753 T3 PL1708753 T3 PL 1708753T3
Authority
PL
Poland
Prior art keywords
veterinary treatment
goat serum
treatment
medicament
veterinary
Prior art date
Application number
PL04820092T
Other languages
Polish (pl)
Inventor
Graham Joseph Peck
Juliette Peck
Original Assignee
Aimsco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0328650A external-priority patent/GB0328650D0/en
Priority claimed from GB0404533A external-priority patent/GB0404533D0/en
Priority claimed from GB0404534A external-priority patent/GB0404534D0/en
Application filed by Aimsco Ltd filed Critical Aimsco Ltd
Publication of PL1708753T3 publication Critical patent/PL1708753T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to a medicament for the veterinary treatment of a non-human mammal. The medicament is particularly suited to the treatment of cats, dogs and horses.
PL04820092T 2003-12-11 2004-12-10 The use of goat serum for veterinary treatment PL1708753T3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0328650A GB0328650D0 (en) 2003-12-11 2003-12-11 Treatment equines
GB0404533A GB0404533D0 (en) 2004-03-01 2004-03-01 Treatment of canines
GB0404534A GB0404534D0 (en) 2004-03-01 2004-03-01 Treatment of canines
EP04820092A EP1708753B1 (en) 2003-12-11 2004-12-10 Use of goat serum for veterinary treatment
PCT/GB2004/050040 WO2005056053A1 (en) 2003-12-11 2004-12-10 Use of goat serum for veterinary treatment

Publications (1)

Publication Number Publication Date
PL1708753T3 true PL1708753T3 (en) 2010-07-30

Family

ID=34681900

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04820092T PL1708753T3 (en) 2003-12-11 2004-12-10 The use of goat serum for veterinary treatment

Country Status (11)

Country Link
US (5) US20080031885A1 (en)
EP (2) EP1708753B1 (en)
AT (1) ATE451120T1 (en)
AU (2) AU2004296610B2 (en)
CA (1) CA2548901C (en)
DE (1) DE602004024586D1 (en)
DK (1) DK1708753T3 (en)
ES (1) ES2337795T3 (en)
NZ (2) NZ577823A (en)
PL (1) PL1708753T3 (en)
WO (1) WO2005056053A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013282995B2 (en) 2012-06-25 2018-10-04 Aimsco Limited Formulation comprising CRH and alpha - 2 - immunoglobulin
GB201408171D0 (en) * 2014-05-08 2014-06-25 Aimsco Ltd Formulation and method of manufacture
RU2765542C1 (en) * 2021-07-08 2022-01-31 федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) Method for predicting the severity of acute bacterial cholangiohepatitis in cats

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952194A (en) * 1996-08-01 1999-09-14 Heska Corporation Flea nucleic acid sequences and uses thereof
WO2003064472A2 (en) * 2002-01-28 2003-08-07 Aimsco Limited Treatment of ms with goat serum
CN1736135A (en) * 2003-01-14 2006-02-15 皇家飞利浦电子股份有限公司 Machine suitable for placing a component on a substrate, as well as a method therefor

Also Published As

Publication number Publication date
US20080031885A1 (en) 2008-02-07
EP2177231A3 (en) 2012-08-15
AU2010202668A1 (en) 2010-07-15
EP1708753B1 (en) 2009-12-09
US20090202522A1 (en) 2009-08-13
NZ577823A (en) 2011-03-31
AU2010202668B2 (en) 2012-05-24
AU2004296610A1 (en) 2005-06-23
WO2005056053A1 (en) 2005-06-23
ES2337795T3 (en) 2010-04-29
EP2177231A2 (en) 2010-04-21
NZ547846A (en) 2009-07-31
US20120294951A1 (en) 2012-11-22
US20110244053A1 (en) 2011-10-06
AU2004296610B2 (en) 2010-04-01
US20140178406A1 (en) 2014-06-26
US8617553B2 (en) 2013-12-31
DK1708753T3 (en) 2010-04-26
EP1708753A1 (en) 2006-10-11
ATE451120T1 (en) 2009-12-15
DE602004024586D1 (en) 2010-01-21
CA2548901A1 (en) 2005-06-23
CA2548901C (en) 2015-07-28

Similar Documents

Publication Publication Date Title
MX2009006066A (en) Treatment of pigs with pcv2 antigen.
DE60113301D1 (en) Gel for the treatment of cats and dogs
BR0111914A (en) Endoparasiticidal compositions for voluntary oral absorption by animals
BRPI0607304A2 (en) compounds having analgesic and / or immunostimulant activity
ATE384433T1 (en) CHEW TOYS FOR ANIMALS
ATE336177T1 (en) HYPOALLERGENIC DIETARY COMPOSITION FOR PETS.
DE60302814D1 (en) Device for an animal related action
ITPR20030019A1 (en) ANIMAL LEASH APPLICABLE TO VEHICLE.
DK2022786T3 (en) Foot-and-mouth disease virus for animals belonging to the family suidae or sheep, and methods for the prevention or treatment of foot-and-mouth disease in animals belonging to the family suidae or sheep
PL1708753T3 (en) The use of goat serum for veterinary treatment
DE602004005334D1 (en) Feed additives
NO20020737D0 (en) Fish farming device
BRPI0415032A (en) transgenic animals with major disorders linked to alzheimer's disease
DE50300915D1 (en) DEVICE FOR CLEANING AND CARING FOR DOGS, ESPECIALLY DOG PADS
DK1280404T3 (en) Model of neurodegenerative disease
SE0301280L (en) One-way gate for animals
ATE343786T1 (en) EVALUATION OF AGENTS FOR THE TREATMENT OF SCHIZOPHRENIA
ATE475325T1 (en) ANIMAL FEED COMPOSITION FOR IMPROVING COLOSTRUM
BRPI0403620A (en) transdermal cestoticide, isolated or associated with anthelmintic and or ectoparasiticides and or insect growth inhibitor or insect development inhibitor for the treatment of dogs, cats and horses
GB0003234D0 (en) Method of treatment
DE112022002673A5 (en) DEVICE FOR CARE OF ANIMALS, IN PARTICULAR DOMESTIC CATS
UA37648A (en) METHOD OF TREATMENT OF RESPIRATORY DISEASES IN CALVES
JP3416688B1 (en) Canine cover
BR9905749A (en) Erythropoietin in the treatment of anemia in domestic animals and livestock
ES1051402Y (en) COLLECTOR OF ANIMAL EXCREMENTS.